On Tuesday, Joseph A. Carrabba, Director of United States Antimony (UAMY), purchased 21,300 shares at $4.72 each, totaling $100,536. This marks Carrabba’s first insider buy in the past twelve months. UAMY briefly traded at $5.43 during the session, representing a 15% gain on his investment.
Also on Tuesday, Liane Rae Teplitsky, Chief Operating Officer of Pulse Biosciences, acquired 2,025 shares for $49.37 each, amounting to $99,971. With this transaction, Teplitsky has made two purchases in the past year, with the earlier buy priced at $48.29 per share. Pulse Biosciences is currently down approximately 1.7% on Friday, but Teplitsky’s investment is up about 10.9% based on a trading high of $54.75.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
